Social determinants of drug-susceptible and drug resistant tuberculosis Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Impact and management of TB childhood outbreaks in EU/EEA Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Transmission pattern of MDR-TB in Singapore 2005-2015 Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
A study of tuberculosis in an expatriate Nepalese community in South-East London Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019
Characteristics of tuberculosis (TB) in patients that died from TB in Poland Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
The cost of tuberculosis in Denmark Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
Extrapulmonary tuberculosis (EPTB) in Poland Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
MDR TB treatment results of GFATM program implementation in Tomsk, Russia Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Childhood tuberculosis outbreaks in EU/EEA: A systematic review Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Active case finding of tuberculosis, Tomsk (Russia) Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Knowledge and practices of hospital employees on tuberculosis Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013
The health economics of treating MDR-TB in the Indian private sector Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Delay in pulmonary tuberculosis treatment in Croatia Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013
Factors associated with pulmonary tuberculosis treatment outcome in Kocaeli; Turkey Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014